CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression
Z Liu(National Cancer Institute), Carol J. Thiele(National Cancer Institute), John M. Maris(Children's Hospital of Philadelphia), Javed Khan(Kent State University), Caroline Sizer(National Cancer Institute), Thomas Ried(National Institutes of Health), Beverly A. Mock(National Institutes of Health), Linda Barenboim‐Stapleton(National Institutes of Health), C. Geraldine McMahon(National Cancer Institute), Z Li(National Cancer Institute), Wendy B. London(Dana-Farber Cancer Institute), Val Bliskovsky(National Cancer Institute), Xinyun Yang(National Cancer Institute)
Cited by 98
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571